Author: Ming Zhong; Aijun Sun; Ting Xiao; Ge Yao; Ling Sang; Xia Zheng; Jinyan Zhang; Xuejuan Jin; Lei Xu; Wenlong Yang; Peng Wang; Kai Hu; Dingyu Zhang; Junbo Ge
Title: A Randomized, Single-blind, Group sequential, Active-controlled Study to evaluate the clinical efficacy and safety of a-Lipoic acid for critically ill patients with coronavirus disease 2019(COVID-19) Document date: 2020_4_21
ID: mvsnybbo_31
Snippet: After a 30-day follow-up, the 30-day all-cause mortality was 77.8% (7/9) in the placebo group, and 37.5% (3/8) in the ALA group (Figure. 3) . The 30-day all-cause mortality was numerically lower in the ALA group than in the placebo group, a borderline statistical significance was observed (P=0.09)......
Document: After a 30-day follow-up, the 30-day all-cause mortality was 77.8% (7/9) in the placebo group, and 37.5% (3/8) in the ALA group (Figure. 3) . The 30-day all-cause mortality was numerically lower in the ALA group than in the placebo group, a borderline statistical significance was observed (P=0.09).
Search related documents:
Co phrase search for related documents- ALA group and placebo group: 1, 2, 3, 4
- borderline statistical significance and placebo group: 1
- borderline statistical significance and statistical significance: 1, 2, 3, 4
- cause mortality and placebo group: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30
- cause mortality and statistical significance: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19
- placebo group and statistical significance: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17
Co phrase search for related documents, hyperlinks ordered by date